Product Description: 3′-Azido-2′,3′-dideoxy-5-hydroxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Applications: Cancer-programmed cell death
Formula: C9H11N5O5
References: [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.
CAS Number: 111495-90-0
Molecular Weight: 269.21
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Nucleoside Antimetabolite/Analog